Validation of Hepa-index as a non-invasive biomarkers panel for assessment of hepatic fibrosis in Egyptians with chronic hepatitis C

@inproceedings{Alboraie2017ValidationOH,
  title={Validation of Hepa-index as a non-invasive biomarkers panel for assessment of hepatic fibrosis in Egyptians with chronic hepatitis C},
  author={Mohamed Alboraie and Kerstin Sch{\"u}tte and Marwa Khairy and Marwa Elsharkawy and Noha Asem and Fathy G. Elghamry and Helmy A. Shalaby and Gamal M. Esmat and P Malfertheiner},
  booktitle={Saudi medical journal},
  year={2017}
}
OBJECTIVES To validate the diagnostic performance of Hepa-Index in predicting different stages of hepatic fibrosis in Egyptian patients with chronic hepatitis C (CHC). Methods: Hundred treatment naïve chronic hepatitis C Egyptian patients were prospectively enrolled between June 2014 and January 2015. They were subjected to: platelet count, alpha-2-macroglobulin (α2-MG), total bilirubin, gamma glutamyl transpeptidase (GGT), total cholesterol, liver biopsy and histopathological staging of… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 21 REFERENCES

Acceptability, reliability and applicability of liver biopsy and non-invasive methods for assessment of hepatic fibrosis and cirrhosis among hepatologists; a web based survey

M Alboraie, A Khairy M. Elsharkawy, N Asem, M El Kassas, F Elghamry
  • Journal of Hepatology
  • 2015
VIEW 1 EXCERPT